VCRE
Vicore Pharma Holding AB
9.40$
-0.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
Vicore Pharma Holding AB (VCRE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -156 million SEK. Tick rows to compare them in a chart.
All figures in millions of SEK.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| -51 | -86 | -106 | – | -81 | -118 | -156 | – | |
| 24 | 2.6 | -0.6 | – | 37 | 2.4 | -15 | – | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | 0.0 | – | – | – | 0.0 | – | |
| 818 | -420 | -357 | – | 112 | -206 | 49 | – | |
| -51 | -86 | -106 | – | -81 | -118 | -156 | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.